SCHEMBL6357532

SCHEMBL6357532

O=C(O)Cc1cccc(S(=O)(=O)N2CCN(c3ccccc3)CC2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.58
SMN1; SMN2 Q16637 3/20 0.57
LMNA P02545 3/20 0.57
ALDH1A1 P00352 2/20 0.57
TDP1 Q9NUW8 1/20 0.57
POLB P06746 1/20 0.57
HDAC3 O15379 1/20 0.56
HDAC4 P56524 1/20 0.56
HDAC1 Q13547 1/20 0.56
HDAC7 Q8WUI4 1/20 0.56
HDAC2 Q92769 1/20 0.56
HDAC10 Q969S8 1/20 0.56
HDAC11 Q96DB2 1/20 0.56
HDAC8 Q9BY41 1/20 0.56
HDAC6 Q9UBN7 1/20 0.56
HDAC9 Q9UKV0 1/20 0.56
HDAC5 Q9UQL6 1/20 0.56
THRB P10828 1/20 0.55
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5772658 0.90 PTPN11 (0.62) HTTLMNAALDH1A1HDAC3HDAC4
SCHEMBL5776880 0.90 LMNA (0.59) SMN1; SMN2LMNAALDH1A1TDP1HDAC3
SCHEMBL5772884 0.90 ALDH1A1 (0.57) HTTSMN1; SMN2LMNAALDH1A1POLB
SCHEMBL5749547 0.89 MEN1 (0.54) HTTSMN1; SMN2LMNAALDH1A1TDP1
SCHEMBL5749603 0.87 PTPN11 (0.59) LMNAALDH1A1MEN1KMT2APTPN11
SCHEMBL5748241 0.87 HTT (0.63) HTTSMN1; SMN2LMNAALDH1A1MEN1
SCHEMBL5746692 0.87 TNF (0.54) HTTSMN1; SMN2LMNAALDH1A1TDP1
SCHEMBL5749090 0.87 LMNA (0.60) SMN1; SMN2LMNAALDH1A1POLBHDAC3
SCHEMBL6348350 0.87 HSD11B1 (0.59) HTTSMN1; SMN2LMNAALDH1A1TDP1
SCHEMBL5749330 0.87 THRB (0.58) HTTSMN1; SMN2LMNAALDH1A1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050234046-A1 Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders KALYPSYS, INC. (US) 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234046-A1 Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders PPARA, PPARG, PPARD HTT 1160/4885SMN1; SMN2 2173/4885LMNA 3289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.